Please login to the form below

Not currently logged in
Email:
Password:

Lucid launches rare and specialist disease agency

Vivid MedComms will be headed by Alison Cantle

VividUK-based Lucid Group, has opened Vivid Medcomms, a new agency that will focus on rare diseases and be based in Buckinghamshire, UK.

Vivid will be headed up by managing director Alison Cantle, who was previously a business unit director at Lucid and has over 20 years’ medical communications experience.

She said: “Our business in rare diseases has increased threefold over the last year and making the decision to create a new stand-alone company focused on this area is an obvious choice.”

According to analysts at Evaluate Pharma sales of orphan drugs are set to account for 20% of all prescription drug sales by 2020.

The move mirrors an “industry-wide shift” towards focusing on rare and specialist disease, with revenues from orphan drugs ‘outpacing’ sales of mainstream drugs for the last decade, explained Lucid.

Cantle added: “We have developed a dedicated and talented team of account handlers and medical writers brimming with a specific skills and experience related to developing excellent comms programmes in rare diseases.

“The team are excited by the challenge and looking forward to transforming the lives of both clients and teams in this space.”

Article by
Gemma Jones

13th November 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics